Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Freeport-McMoRan Inc (FCX) vs Tilray Brands Inc (TLRY) Price & Performance

Freeport-McMoRan IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Freeport-McMoRan Inc vs Tilray Brands Inc — how do they compare? Freeport-McMoRan Inc trades at $59.24 (market cap $87.65B), while Tilray Brands Inc trades at $4.39 (market cap $541.36M). The key difference: Freeport-McMoRan Inc is far larger — about 161.9× Tilray Brands Inc's market cap, and Freeport-McMoRan Inc pays a 0.98% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

FCXTLRY
Market Cap
$87.65B$541.36M
Sector
Basic MaterialsHealth
52-Week High
$71.73$21.00
52-Week Low
$35.34$4.31
Enterprise Value
$94.31B$638.50M
Dividend Yield
0.98%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Freeport-McMoRan Inc

Freeport-McMoRan (FCX) trades at $61.97, up 3.33% with a bearish technical signal despite three consecutive quarterly earnings beats. The copper miner shows improving fundamentals with revenue growth to $25.92B and net income of $2.20B in 2025, supported by strong copper demand. Analyst consensus remains bullish with a $72.94 price target, though the stock faces technical resistance near $63-64 levels.

FCX presents a compelling value proposition with expanding profit margins and strategic positioning in the copper market, though investors face volatility risks from commodity price fluctuations and ongoing negative cash flow trends. The company's expansion pipeline and dividend payments provide additional shareholder value drivers.

Tilray Brands Inc

TLRY trades at $4.355, down 0.57% on the day, amid a bearish technical signal and weak earnings performance. The company reported a net loss of $2.19 billion in 2025, with a negative net income margin of -156.67%, while revenue grew to $821.31 million. Recent news includes medical cannabis expansion in Panama and the acquisition of HelloMD to enhance digital healthcare capabilities.

The outlook remains challenging due to persistent losses and high debt levels, though low valuation ratios like P/S of 0.55 and P/B of 0.35 may attract value investors. Key risks include profitability struggles, regulatory uncertainty, and competitive pressures in the cannabis sector. Analyst sentiment is mixed, with 65% hold ratings reflecting caution.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Freeport-McMoRan Inc

Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia

Read more on FCX

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY